INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,589 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SB
Starr Daniel BrianDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A$186
3 sh
Feb 5, 2026Feb 6, 2026
Page 1317 of 1765
← PrevNext →
traded Feb 5, 2026
+1d
SEC Form 4

Evidence

9
SJ
Schlosser JosephEVP, Chief Operating Officer
PECOPhillips Edison & Company, Inc.
Grant or award
A—
1,018 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
SS
Stiles Spencer SPresident and COO
SYKSTRYKER CORP
Grant or award
A—
20.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
PA
Pierce James AndrewGroup President
SYKSTRYKER CORP
Grant or award
A—
2,771 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
AI
Adler Michael IEVP, CTPO
NABLN-able, Inc.
Tax withholding
F$45K
7,976 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
YR
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
VERAVera Therapeutics, Inc.
Grant or award
A—
20.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
CM
Conner Penelope MDirector
ESEESCO TECHNOLOGIES INC
Disposition to issuer
D$60.46
0 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

9
MA
Musial Nickolas A.VP, Controller & CAO
ALLEAllegion plc
Tax withholding
F$32K
188 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
AM
Angel MatthewDirector, CEO and President, 10% Owner
TPSTTempest Therapeutics, Inc.
Grant or award
A—
269.6K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
BR
Boodhoo RoshanDirector
APACStoneBridge Acquisition II Corp
Grant or award
A—
25.0K sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

9
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Tax withholding
F—
589 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
HB
Heselton BenjaminChief Information Officer
LWLamb Weston Holdings, Inc.
Grant or award
A—
59.8K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
YJ
Younes Steven JCHIEF HUMAN RESOURCES OFFICER
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

7
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$263K
2,051 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

7
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$471K
3,648 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

6
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$132K
869 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$79K
496 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

5
CL
Charlton Rebecca LSVP, Controller & CAO
BKRBaker Hughes Co
Grant or award
A—
5,201 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

5
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Grant or award
A$21K
89 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

5
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
260.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

5
WW
Wells Preston WendellVP, Chief Financial Officer
SYKSTRYKER CORP
Grant or award
A—
12.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

5
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
646.7K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

4
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$63K
500 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

4
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$51K
400 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
6,526 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

2
SM
Sharma ManishChief Strategy & Services Ofcr
ACNAccenture plc
Grant or award
A$18K
76 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

2
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Grant or award
A$17K
73 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

1
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$26K
200 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
6,448 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$98K
502 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
8,606 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

53
TE
Tryniski Mark EDirector
TBBKBancorp, Inc.
Open-market purchase
BUY$301K
5,000 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

49
MP
McCourt Stephen PatrickCo-CEO of Sub Advisor
MIFAXMeketa Infrastructure Fund
Open-market purchase
BUY$55K
1,955 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

49
MP
McCourt Stephen PatrickCo-CEO of Sub Advisor
PMPEXPrimark Meketa Private Equity Investments Fund
Open-market purchase
BUY$55K
3,709 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

46
BF
Bacon Elise FrazerConsultant of Sub Advisor
MIFAXMeketa Infrastructure Fund
Open-market purchase
BUY$10,000
355 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

46
WS
Woolley Peter ScottCO-CEO of Sub Advisor
PMPEXPrimark Meketa Private Equity Investments Fund
Open-market purchase
BUY$50K
3,372 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

45
CM
Chu MaggieSVP, CHRO
LFUSLITTELFUSE INC /DE
Open-market sale
SELL$673K
2,061 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence

38
DS
Desmond SeanDirector, CEO & President
NCNOnCino, Inc.
Open-market sale
SELL$300K
16.0K sh
Feb 3, 2026Feb 5, 2026
traded Feb 3, 2026
+2dSEC Form 4

Evidence

36
KT
Krasnow ToddDirector
SYMSymbotic Inc.
Open-market sale · 10b5-1 plan
SELL$120K
2,215 sh
Feb 2, 2026Feb 5, 2026
traded Feb 2, 2026
+3dSEC Form 4

Evidence

35
PT
Parang TourajDirector, President & COO
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$62K
5,998 sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC Form 4

Evidence